IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$773M
AUM Growth
+$278M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1 +$33.1M
2 +$14.6M
3 +$14.3M
4
OLMA icon
Olema Pharmaceuticals
OLMA
+$13.5M
5
LLY icon
Eli Lilly
LLY
+$13.2M

Top Sells

1 +$53M
2 +$20.7M
3 +$16M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$13.6M
5
PTCT icon
PTC Therapeutics
PTCT
+$11.8M

Sector Composition

1 Healthcare 99.47%
2 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMTX icon
101
Immatics
IMTX
$1.36B
$510K 0.07%
48,569
-827
EQ icon
102
Equillium
EQ
$108M
$471K 0.06%
303,555
-28,742
OVID icon
103
Ovid Therapeutics
OVID
$120M
$404K 0.05%
247,558
-848,016
IMUX icon
104
Immunic
IMUX
$141M
$360K 0.05%
674,662
-239,508
EVAX
105
Evaxion A/S
EVAX
$26M
$356K 0.05%
74,698
-5,302
VTGN icon
106
VistaGen Therapeutics
VTGN
$24.2M
$344K 0.04%
519,077
-101,792
VKTX icon
107
Viking Therapeutics
VKTX
$3.69B
$342K 0.04%
9,717
-283
GPCR icon
108
Structure Therapeutics
GPCR
$4.45B
$336K 0.04%
4,824
-158,413
RARE icon
109
Ultragenyx Pharmaceutical
RARE
$2.13B
$291K 0.04%
+12,671
VERU icon
110
Veru
VERU
$40.4M
$286K 0.04%
133,517
-9,006
CNSP icon
111
CNS Pharmaceuticals
CNSP
$1.89M
$241K 0.03%
+45,830
SNSE icon
112
Sensei Biotherapeutics
SNSE
$39.7M
$228K 0.03%
21,351
-1,146
NYXH
113
Nyxoah
NYXH
$170M
$218K 0.03%
47,358
-3,269
VYGR icon
114
Voyager Therapeutics
VYGR
$226M
$209K 0.03%
53,063
-2,703
LXRX icon
115
Lexicon Pharmaceuticals
LXRX
$673M
$189K 0.02%
164,674
-11,805
NEUP
116
Neuphoria Therapeutics
NEUP
$25M
$184K 0.02%
+47,443
GCTK icon
117
GlucoTrack
GCTK
$1.42M
$177K 0.02%
+45,830
VYNE icon
118
VYNE Therapeutics
VYNE
$19.5M
$154K 0.02%
264,912
-25,088
RNAC icon
119
Cartesian Therapeutics
RNAC
$195M
$150K 0.02%
20,807
-1,359
SHPH icon
120
Shuttle Pharmaceuticals
SHPH
$2.9M
$124K 0.02%
+68,993
MGNX icon
121
MacroGenics
MGNX
$120M
$121K 0.02%
74,893
-5,178
PMVP icon
122
PMV Pharmaceuticals
PMVP
$86.2M
$111K 0.01%
89,136
-8,364
PURR
123
Hyperliquid Strategies Inc
PURR
$626M
$107K 0.01%
+30,001
MGRX icon
124
Mangoceuticals
MGRX
$6.24M
$102K 0.01%
+138,146
CMMB
125
Chemomab Therapeutics
CMMB
$11M
$85.5K 0.01%
51,793
-1,469